Literature DB >> 1333884

Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma.

S A Reeves1, C Chavez-Kappel, R Davis, M Rosenblum, M A Israel.   

Abstract

In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6). We also detected high levels of annexin II expression in fetal brain during the period when radial glia proliferate, although annexin II expression was not detected in normal adult brain. These data demonstrate that annexin II expression is developmentally regulated in the human central nervous system and suggest that the early progenitor radial glia share important characteristics with highly malignant glial tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333884

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  Specific down-regulation of annexin II expression in human cells interferes with cell proliferation.

Authors:  Y Chiang; A Rizzino; Z A Sibenaller; M S Wold; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis.

Authors:  N Aktug Demir; S Kolgelier; S Sumer; A C Inkaya; S Ozcimen; L S Demir; O Ural; A Arpaci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-23       Impact factor: 3.267

3.  Cell cycle and post-transcriptional regulation of annexin expression in IMR-90 human fibroblasts.

Authors:  P Raynal; H B Pollard; M Srivastava
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

4.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

Authors:  T Tanaka; S Kondo; Y Iwasa; H Hiai; S Toyokuni
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.

Authors:  Romain Marlin; Angela Pappalardo; Hannah Kaminski; Carrie R Willcox; Vincent Pitard; Sonia Netzer; Camille Khairallah; Anne-Marie Lomenech; Christelle Harly; Marc Bonneville; Jean-François Moreau; Emmanuel Scotet; Benjamin E Willcox; Benjamin Faustin; Julie Déchanet-Merville
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

6.  Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus.

Authors:  D A Eberhard; M D Brown; S R VandenBerg
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Authors:  Kamala Kesavan; Judson Ratliff; Eric W Johnson; William Dahlberg; John M Asara; Preeti Misra; John V Frangioni; Douglas B Jacoby
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

8.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064

Review 9.  Annexin A2 system in human biology: cell surface and beyond.

Authors:  Min Luo; Katherine A Hajjar
Journal:  Semin Thromb Hemost       Date:  2013-03-12       Impact factor: 4.180

10.  Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Authors:  Y Ohno; M Izumi; T Kawamura; T Nishimura; K Mukai; M Tachibana
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.